You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雅各臣科研製藥(02633.HK)擬4165萬港元出售康寧行49%股權
格隆匯 06-01 17:38

格隆匯6月1日丨雅各臣科研製藥(02633.HK)公佈,於2020年6月1日,賣方Coming Wealth Inc.(公司間接全資附屬公司)與買方Million Effort Investment Limited訂立該協議,賣方有條件同意出售目標公司康寧行有限公司49%股權,總代價4165萬港元。

目標公司為於2017年2月23日在香港註冊成立的有限公司,主要從事投資控股。於本公告日期,目標公司持有香港附屬公司全部股本權益,該公司為一間於1992年5月14日在香港註冊成立的有限公司,為主要透過其零售店從事中藥及醫藥產品零售及批發業務的營運公司。

公司稱,集團自2017年起與滿貫集團建立及一直維持業務合作,分銷集團品牌藥產品,而公司間接全資附屬公司Jacobson Group Treasury Limited為滿貫集團全球發售的基石投資者。於進行出售事項後,集團繼續持有目標公司21%股本權益。透過此戰略合作,集團及香港附屬公司的批發與零售業務可善用滿貫集團的市場經驗、專長及網絡,尤其是滿貫集團透過其澳門零售店進行線下直接銷售及透過其跨境電子商業平台於進行線上銷售的零售經驗。

出售事項亦可讓集團重新分配更多資源,推動其非專利藥及品牌醫療保健業務的持續發展。鑑於公司與滿貫集團現有的業務聯繫及不斷增加的合作範疇,董事認為,出售事項將有利集團促進及加強與滿貫集團的戰略合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account